Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $8.1250 (6.14%) ($8.1250 - $8.1250) on Fri. Apr. 21, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.01% (three month average) | RSI | 62 | Latest Price | $8.1250(6.14%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT advances 1.3% a day on average for past five trading days. | Weekly Trend | EDIT advances 7.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) XBI(66%) IBB(53%) IWC(51%) IWO(47%) IWM(46%) | Factors Impacting EDIT price | EDIT will decline at least -2.505% in a week (0% probabilities). IGOV(-15%) SMH(-14%) VXX(-12%) VIXM(-11%) BNDX(-9%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.505% (StdDev 5.01%) | Hourly BBV | 1.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $8.02(1.31%) | 10 Day Moving Average | $7.54(7.76%) | 20 Day Moving Average | $7.34(10.69%) | To recent high | -28.9% | To recent low | 27.9% | Market Cap | $505m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |